Atea Pharmaceuticals Inc (AVIR)

Finanzdaten der Atea Pharmaceuticals Inc-Aktie (AVIR)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
	26.89%35.10	48.01	54.93	45.57	41.35
Research and Development	31.57%28.15	41.13	47.82	38.35	32.28
Depreciation and Amortization	0.10	0.10	0.10	0.10	0.10
Operating Income/Loss	26.89%-35.10	-48.01	-54.93	-45.57	-41.35
Income/Loss From Continuing Operations Before Tax	27.50%-32.91	-45.39	-51.64	-41.85	-36.95
Income Tax Expense/Benefit	52.00%0.02	0.05	-6.77	0.20	0.21
	27.52%-32.93	-45.44	-44.87	-42.05	-37.16
Attributable To Parent	27.52%-32.93	-45.44	-44.87	-42.05	-37.16
Basic Average Shares	1.08%80.05	79.20	-1.13	79.05	83.75
Diluted Average Shares	1.08%80.05	79.20	-1.13	79.05	83.75
Basic Earnings Per Share	28.07%-0.41	-0.57	-0.57	-0.53	-0.44
Diluted Earnings Per Share	28.07%-0.41	-0.57	-0.57	-0.53	-0.44